Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
14.00
+0.43 (3.17%)
At close: Mar 9, 2026, 4:00 PM EDT
14.20
+0.20 (1.43%)
After-hours: Mar 9, 2026, 5:55 PM EDT
Theravance Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 709 | 463 | 560 | 755 | 814 | 1,137 | |
| Market Cap Growth | 49.35% | -17.33% | -25.82% | -7.35% | -28.37% | -22.63% | |
| Enterprise Value | 421 | 416 | 477 | 320 | 1,269 | 1,398 | |
| Last Close Price | 14.00 | 9.41 | 11.24 | 11.22 | 11.05 | 17.77 | |
| PE Ratio | 24.13 | - | - | 0.87 | - | - | |
| PS Ratio | 8.83 | 7.19 | 9.75 | 14.70 | 14.72 | 15.82 | |
| PB Ratio | 3.05 | 2.64 | 2.63 | 1.71 | -2.40 | -3.74 | |
| P/TBV Ratio | 3.05 | 2.64 | 2.63 | 1.71 | - | - | |
| EV/Sales Ratio | 5.24 | 6.47 | 8.30 | 6.23 | 22.95 | 19.46 | |
| Debt / Equity Ratio | 0.19 | 0.28 | 0.23 | 0.12 | -1.98 | -2.23 | |
| Net Debt / Equity Ratio | -1.24 | -0.22 | -0.25 | -0.62 | -1.46 | -1.26 | |
| Net Debt / EBITDA Ratio | 9.24 | 0.95 | 1.03 | 3.62 | -2.13 | -1.30 | |
| Net Debt / FCF Ratio | -1.18 | 3.25 | 1.81 | 1.47 | -2.35 | -1.49 | |
| Asset Turnover | 0.21 | 0.18 | 0.12 | 0.11 | 0.13 | 0.16 | |
| Quick Ratio | 9.30 | 4.89 | 4.84 | 11.99 | 3.20 | 2.93 | |
| Current Ratio | 9.48 | 5.02 | 5.39 | 12.31 | 4.26 | 3.18 | |
| Return on Equity (ROE) | 14.03% | -29.04% | -16.86% | -179.84% | - | - | |
| Return on Assets (ROA) | -5.32% | -7.21% | -6.78% | -10.07% | -35.20% | -42.38% | |
| Return on Capital Employed (ROCE) | -8.70% | -13.20% | -15.00% | -13.70% | -75.10% | -86.10% | |
| Earnings Yield | 4.14% | -12.19% | -9.86% | 115.58% | -24.49% | -24.45% | |
| FCF Yield | 34.32% | -2.56% | -5.27% | -24.86% | -25.94% | -22.61% | |
| Buyback Yield / Dilution | -3.49% | 11.67% | 24.85% | -5.95% | -11.41% | -12.11% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.